Literature DB >> 12151537

Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury.

Bharatkumar N Patel1, Robert J Dunn, Suh Young Jeong, Qinzhang Zhu, Jean-Pierre Julien, Samuel David.   

Abstract

Ceruloplasmin is a ferroxidase that oxidizes toxic ferrous iron to its nontoxic ferric form. We have previously reported that a glycosylphosphatidylinositol-anchored form of ceruloplasmin is expressed in the mammalian CNS. To better understand the role of ceruloplasmin in iron homeostasis in the CNS, we generated a ceruloplasmin gene-deficient (Cp(-/-)) mouse. Adult Cp(-/-) mice showed increased iron deposition in several regions of the CNS such as the cerebellum and brainstem. Increased lipid peroxidation was also seen in some CNS regions. Cerebellar cells from neonatal Cp(-/-) mice were also more susceptible to oxidative stress in vitro. Cp(-/-) mice showed deficits in motor coordination that were associated with a loss of brainstem dopaminergic neurons. These results indicate that ceruloplasmin plays an important role in maintaining iron homeostasis in the CNS and in protecting the CNS from iron-mediated free radical injury. Therefore, the antioxidant effects of ceruloplasmin could have important implications for various neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease in which iron deposition is known to occur.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12151537      PMCID: PMC6758125          DOI: 20026652

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  105 in total

Review 1.  Animal models of age related macular degeneration.

Authors:  Mark E Pennesi; Martha Neuringer; Robert J Courtney
Journal:  Mol Aspects Med       Date:  2012-06-15

Review 2.  In vivo structural imaging of the cerebellum, the contribution of ultra-high fields.

Authors:  José P Marques; Rolf Gruetter; Wietske van der Zwaag
Journal:  Cerebellum       Date:  2012-06       Impact factor: 3.847

Review 3.  Murine mutants in the study of systemic iron metabolism and its disorders: an update on recent advances.

Authors:  Thomas B Bartnikas; Mark D Fleming; Paul J Schmidt
Journal:  Biochim Biophys Acta       Date:  2012-01-28

4.  Expression of ceruloplasmin pseudogene in cultured human cells.

Authors:  A V Vasin; N A Platonova; S A Klotchenko; N V Tsymbalenko; L V Puchkova
Journal:  Dokl Biochem Biophys       Date:  2004 Jul-Aug       Impact factor: 0.788

5.  Extrapyramidal and cerebellar movement disorder in association with heterozygous ceruloplasmin gene mutation.

Authors:  Jens Kuhn; Hiroaki Miyajima; Yoshitomo Takahashi; Bernhard Kunath; Ursula Hartmann-Klosterkoetter; Déirdre Cooper-Mahkorn; Mark Schaefer; Heiko Bewermeyer
Journal:  J Neurol       Date:  2005-01       Impact factor: 4.849

6.  Placental expression of ceruloplasmin in pregnancies complicated by severe preeclampsia.

Authors:  Seth Guller; Catalin S Buhimschi; Yula Y Ma; Se Te J Huang; Liubin Yang; Edward Kuczynski; Eduardo Zambrano; Charles J Lockwood; Irina A Buhimschi
Journal:  Lab Invest       Date:  2008-08-04       Impact factor: 5.662

7.  Pooled analysis of iron-related genes in Parkinson's disease: association with transferrin.

Authors:  Shannon L Rhodes; Daniel D Buchanan; Ismaïl Ahmed; Kent D Taylor; Marie-Anne Loriot; Janet S Sinsheimer; Jeff M Bronstein; Alexis Elbaz; George D Mellick; Jerome I Rotter; Beate Ritz
Journal:  Neurobiol Dis       Date:  2013-10-08       Impact factor: 5.996

8.  Expression patterns of iron regulatory proteins after intense light exposure in a cone-dominated retina.

Authors:  Meenakshi Maurya; Tapas C Nag; Pankaj Kumar; Tara Sankar Roy
Journal:  Mol Cell Biochem       Date:  2021-05-13       Impact factor: 3.396

Review 9.  Podocytes and glomerular function with aging.

Authors:  Jocelyn Wiggins
Journal:  Semin Nephrol       Date:  2009-11       Impact factor: 5.299

Review 10.  Aging in the glomerulus.

Authors:  Jocelyn E Wiggins
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-07-25       Impact factor: 6.053

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.